The Future of Cell and Gene Therapy Manufacturing

Thursday, March 14, 2024

Johnson & Johnson

1000 Rte 202 

Raritan, NJ 08869

6:00 PM - 9:00 PM

The upcoming event by the ISPE NJ Chapter will dive in to cell and gene therapy manufacturing with a stellar panel of industry leaders to discuss critical topics including:


  • Utilizing Manufacturing Platforms
  • Increasing Manufacturing Capacity
  • Techniques for Reducing Manufacturing Costs
  • Implementing Closed Systems
  • Applying Automation and Robotics
  • Leveraging Information Technologies such as Manufacturing Execution Systems/Electronic Batch Records and Artificial Intelligence/Machine Learning
  • Deploying Decentralized Manufacturing
  • Future Workforce and Talent Management


The event will be hosted by Johnson and Johnson with dinner and cocktails. Do not miss out on the chapter’s premier event. 

Panel Moderator:

  • Robert Lechich, Principal Consultant, Global OT-IT Quality Services


  • Dominique DeJaeger, VP Johnson and Johnson

  • Innovative Medicines - Autologous Therapies Platform

  • Rich Bland, Senior Director of Supply Chain, Cellares

  • Emily Moran, Senior Vice President of Cell and Gene Manufacturing Center for Breakthrough Medicine

  • Ronit Slotky, PhD, Director Cell Therapies Manufacturing, Hackensack University Medical Center

  • Thomas Heathman, PhD, Chief Commercial Officer, Ori Biotech

  • David Smith, PhD, VP of Development, BioCentriq

Registration Cost

  • Registration $70

  • Sponsorship SOLD OUT